The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
The company also reported significant progress toward its internally defined Sustainable Development Goals
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
The company along with its subsidiaries has overall bed capacity of 8800+ beds as on 30th September, 2025
The center will deliver Certified Pre-Owned instruments restored to factory-grade standards and backed by Agilent Standard Warranty
The pharmaceutical giant now expects 2026 revenues to land between $59.5 billion and $62.5 billion
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
Subscribe To Our Newsletter & Stay Updated
